Metabolic Pharmaceuticals' clinical trials for obesity treatment ultimately did not meet primary endpoints, and the compound was not approved as an obesity drug
Over time high blood sugar can cause serious health problems, including heart disease, vision loss, and kidney disease
Glutathione is a tripeptide (small protein) made from three amino acids: cysteine, glycine, and glutamate
Animal studies report effects on tendon, ligament, and gastrointestinal tissue repair, but no Phase 3 human trials have been completed
NICE guidelines recommend specific GLP-1 receptor agonists as part of a comprehensive approach to diabetes management (NG28) and, in specific circumstances, for weight management in individuals with obesity or overweight with comorbidities (TA875 for semaglutide, TA664 for liraglutide)
Glow routines should adapt to life stages